<HashMap><database>ecrin-mdr-crc</database><scores/><additional><omics_type>Clinical</omics_type><study_start_year>2013</study_start_year><condition>Surgical Site Infection</condition><condition>Colorectal Cancer</condition><condition>Colorectal Neoplasms</condition><condition>Infections</condition><condition>Communicable Diseases</condition><condition>Surgical Wound Infection</condition><disease>Surgical Site Infection</disease><disease>Colorectal Cancer</disease><disease>Colorectal Neoplasms</disease><disease>Infections</disease><disease>Communicable Diseases</disease><disease>Surgical Wound Infection</disease><study_type>Interventional</study_type><full_dataset_link>https://newmdr.ecrin.org/Study/2199762</full_dataset_link><location>Brazil</location><study_start_month>10</study_start_month><keyword>Symbiotic</keyword><repository>ECRIN MDR</repository><study_status>Not provided</study_status></additional><is_claimable>false</is_claimable><name>Symbiotics to Prevent Postoperative Infection in Colorectal Cancer</name><description>This is a double blind randomized trial in which patients with colorectal cancer undergoing surgery will be selected to receive either a symbiotic formulation or placebo. The researchers will compare incidence of surgical site infection between the study groups.</description><dates><creation>2013-10-15</creation></dates><accession>2199762</accession><cross_references><ClinicalTrials___gov>NCT02571374</ClinicalTrials___gov></cross_references></HashMap>